| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 2,520 | 2,472 | 2,887 | 3,760 | | Cost of Revenue | 1,040 | 1,017 | 1,036 | 1,221 | | | Gross Profit | 1,480 | 1,455 | 1,851 | 2,539 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 3,809 | 2,530 | 2,556 | 2,986 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (2,329) | (1,075) | (705) | (447) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 34 | (13) | (71) | (27) | | Earnings Before Interest And Taxes | (2,295) | (1,088) | (776) | (474) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (2,295) | (1,088) | (776) | (474) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,295) | (1,088) | (776) | (474) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,295) | (1,088) | (776) | (474) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,295) | ($1,088) | ($776) | ($474) |
|
0.49% Nasdaq 
Income Statement
